|
Sep 23
|
EMA Committee Endorses AbbVie's Elahere in Ovarian Cancer
|
|
Sep 22
|
Is AbbVie (NYSE:ABBV) A Risky Investment?
|
|
Aug 29
|
Neurocrine Stock Down 19% on Mixed Schizophrenia Study Results
|
|
Aug 29
|
Why Is Pfizer (PFE) Down 5.9% Since Last Earnings Report?
|
|
Aug 29
|
AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know
|
|
Aug 29
|
Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now?
|
|
Aug 29
|
Bull Market Buys: 3 Dividend Stocks to Own for the Long Run
|
|
Aug 28
|
As Regulators Gear Up To Decide On Bristol Myers' Schizophrenia Treatment, Neurocrine Biosciences' Data Disappoints Investors
|
|
Aug 28
|
Prediction: Eli Lilly's Latest Move Will Threaten AbbVie Stock
|
|
Aug 27
|
AbbVie Awards Scholarships to 45 U.S. Students Living With Chronic Immune-Mediated Diseases
|
|
Aug 27
|
SkinMedica® Revolutionizes Skin Hydration with the Introduction of HA5® Hydra Collagen Replenish + Restore Hydrator
|
|
Aug 27
|
Should Invesco Large Cap Value ETF (PWV) Be on Your Investing Radar?
|
|
Aug 26
|
Donald Trump Owns These 21 Dividend Kings. Should You?
|
|
Aug 25
|
3 Unstoppable Dividend Stocks to Buy Right Now
|
|
Aug 25
|
Should You Be Excited About AbbVie Inc.'s (NYSE:ABBV) 78% Return On Equity?
|
|
Aug 23
|
Pharma Stock Roundup: FDA Nod to PFE, MRNA New COVID Jabs & More
|
|
Aug 23
|
Analysis: Ozempic on Wall Street's list for 2027 Medicare drug negotiations
|
|
Jan 16
|
AbbVie (ABBV) Registers a Bigger Fall Than the Market: Important Facts to Note
|
|
Jan 16
|
Q4 Earnings Season Scorecard and Analyst Reports for Apple, AbbVie & Toyota
|
|
Jan 16
|
Better Growth Stock: Abbott vs. AbbVie
|